This year, World Malaria Day is running with the backdrop of countries around the world continuing to fight the COVID-19 pandemic.

The event, called “Improving care for chronic patients in lower-income countries: the patient journey,” will take place November 29, 2016, on the Novartis Campus in Basel, Switzerland and will also be webcast.

The event will take place on November 21 in Basel.

European Patient Innovation Summit publishes a position paper on Digital Health from a Patient Perspective with recommendations on digital health.

EPIS participants call for all stakeholders to ensure the patient voice is at the heart of the development of digital health solutions

Novartis revealed the healthcare and pharma industry has emerged as a desired career destination for tech talent during the COVID-19 pandemic, in the Powerful Pairing research report launched today.

Novartis joins seven global companies to found the Value Balancing Alliance

Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.

Leprosy is an ancient disease that currently infects more than 200 000 people each year. For more than three decades, Novartis and the Novartis Foundation has been working to reduce the incidence of leprosy, and the Novartis Foundation recently helped establish the Global Partnership for Zero Leprosy in an effort to eliminate the disease.